Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Remifentanil in Neurosurgical Intervention
ChiCTR-IPR-16008494Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- May 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and remifentanil in pain (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: Vital signs and Vasoactive drugs. Planned start May 2016; status: not yet recruiting.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR-IPR-16008494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008494.